We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $748M
1-Year Est. Return 27.21%
This Fund
S&P 500
This Quarter Est. Return
+1.25%
1 Year Est. Return
+27.21%
3 Year Est. Return
+69.53%
5 Year Est. Return
+110.76%
10 Year Est. Return
–
AUM
$268M
AUM Growth
+$5.72M
Cap. Flow
+$3.93M
Cap. Flow %
1.46%
Top 10 Hldgs %
30.56%
Holding
77
New
2
Increased
36
Reduced
30
Closed
2

Top Buys

Rank Stock Value
1
CLB icon
Core Laboratories
CLB
+$2.14M
2
KDP icon
Keurig Dr Pepper
KDP
+$1.04M
3
DLX icon
Deluxe
DLX
+$873K
4
GPN icon
Global Payments
GPN
+$562K
5
TJX icon
TJX Companies
TJX
+$438K

Top Sells

Rank Stock Value
1
OXY icon
Occidental Petroleum
OXY
+$2.03M
2
BBBY
Bed Bath & Beyond Inc
BBBY
+$793K
3
UNH icon
UnitedHealth
UNH
+$734K
4
GILD icon
Gilead Sciences
GILD
+$669K
5
ABT icon
Abbott
ABT
+$574K

Sector Composition

Rank Sector Weight
1 Healthcare 20.82%
2 Technology 19%
3 Industrials 17.73%
4 Consumer Discretionary 16.49%
5 Consumer Staples 10.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
1
Oracle
ORCL
$457B
$9.39M 3.5%
229,550
+2,755
+1% +$105K
MA icon
2
Mastercard
MA
$507B
$9.07M 3.38%
121,401
-779
-0.6% -$60.9K
GILD icon
3
Gilead Sciences
GILD
$187B
$8.82M 3.29%
124,457
-8,534
-6% -$669K
MKC icon
4
McCormick & Company Non-Voting
MKC
$14B
$8.34M 3.11%
232,552
+10,374
+5% +$349K
CTSH icon
5
Cognizant
CTSH
$28.1B
$8.33M 3.11%
164,650
+4,188
+3% +$209K
NEU icon
6
NewMarket
NEU
$8.14B
$8.24M 3.07%
21,089
+450
+2% +$160K
AME icon
7
Ametek
AME
$54.5B
$7.85M 2.92%
152,405
-4,606
-3% -$238K
MSFT icon
8
Microsoft
MSFT
$3.71T
$7.56M 2.82%
184,404
+4,379
+2% +$164K
ACN icon
9
Accenture
ACN
$114B
$7.32M 2.73%
91,825
+2,142
+2% +$176K
PII icon
10
Polaris
PII
$3.56B
$7.08M 2.64%
50,719
+419
+0.8% +$56.5K
OA
11
DELISTED
Orbital ATK, Inc.
OA
$7.08M 2.64%
49,806
-1,729
-3% -$231K
APH icon
12
Amphenol
APH
$204B
$7.04M 2.62%
1,228,608
-4,592
-0.4% -$25.6K
GGG icon
13
Graco
GGG
$12.6B
$6.67M 2.49%
267,867
+3,477
+1% +$87K
PEP icon
14
PepsiCo
PEP
$188B
$6.43M 2.4%
77,015
+2,919
+4% +$237K
BCR
15
DELISTED
CR Bard Inc.
BCR
$5.97M 2.23%
40,374
-82
-0.2% -$11.3K
ROL icon
16
Rollins
ROL
$17.3B
$5.97M 2.23%
666,492
+5,765
+0.9% +$50.3K
AAPL icon
17
Apple
AAPL
$4.67T
$5.84M 2.18%
304,780
+15,176
+5% +$289K
SYK icon
18
Stryker
SYK
$116B
$5.78M 2.15%
70,964
-475
-0.7% -$37.8K
VAR
19
DELISTED
Varian Medical Systems, Inc.
VAR
$5.77M 2.15%
78,354
+563
+0.7% +$40.5K
TTC icon
20
Toro Company
TTC
$8.83B
$5.67M 2.11%
179,560
+1,832
+1% +$58.9K
NKE icon
21
Nike
NKE
$57B
$5.61M 2.09%
151,950
-3,064
-2% -$116K
ROST icon
22
Ross Stores
ROST
$73.7B
$5.53M 2.06%
154,438
+4,370
+3% +$155K
SEIC icon
23
SEI Investments
SEIC
$13.2B
$5.37M 2%
159,922
+423
+0.3% +$14.4K
TJX icon
24
TJX Companies
TJX
$145B
$5.21M 1.94%
171,816
+14,458
+9% +$438K
SLGN icon
25
Silgan Holdings
SLGN
$4.35B
$5.2M 1.94%
209,876
+10,172
+5% +$242K
1
2 3 4

Similar funds

VCM
Virtue Capital Management Brentwood, Tennessee $749M AUM 40.13% 1-Year Est. Return
QI
Qtron Investments Boston, Massachusetts $750M AUM 44.01% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
BCM
Bienville Capital Management New York $750M AUM 2.59% 1-Year Est. Return
BG
BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return
PCM
Permanent Capital Management Chicago, Illinois $747M AUM 17.94% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

JLB & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, JLB & Associates held 77 positions worth $268M, up 2.2% from $263M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

JLB & Associates's Q1 2014 filing shows 2 new, 36 increased, 30 reduced and 2 closed positions. Its largest new stake was Keurig Dr Pepper: 20,566 shares worth $1.12M. The largest sale was Occidental Petroleum, an estimated $2.03M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

  • JLB & Associates's largest Q1 2014 buy was Keurig Dr Pepper: 20,566 shares worth $1.12M.
  • JLB & Associates added most to Core Laboratories in Q1 2014, an estimated $2.14M increase.
  • JLB & Associates's biggest Q1 2014 reduction was Occidental Petroleum, cutting an estimated $2.03M.
  • JLB & Associates fully exited Bed Bath & Beyond Inc in Q1 2014, selling an estimated $793K.
  • JLB & Associates's ten largest holdings make up 31% of its $268M portfolio in Q1 2014.
  • JLB & Associates opened 2 new positions and closed 2 in Q1 2014.
  • JLB & Associates's portfolio value rose 2.2% quarter-over-quarter to $268M.

Based on JLB & Associates's 13F filing for Q1 2014, filed 4 Apr 2014.